BCG revaccination for healthcare workers in SARS-CoV-2 pandemic
Clinical trial in South Africa to evaluate the potential of BCG as a COVID-19 vaccine. The contributions of the groups under IISA umbrella (Pedro Baptista, Santiago Ramon-García and Rosa Bolea) will be in kind to evaluate in the lung organoid model the potential of the BCG vaccines. Information from the clinical trial will feed model experimentation. This in kind contribution is provided alternative funding sources are secure.
IISA leader for this consortium is Santiago Ramón-García.